Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CCR4-bearing T cells participate in autoimmune diabetes
Soon H. Kim, Mary M. Cleary, Howard S. Fox, David Chantry, Nora Sarvetnick
Soon H. Kim, Mary M. Cleary, Howard S. Fox, David Chantry, Nora Sarvetnick
View: Text | PDF
Article Immunology

CCR4-bearing T cells participate in autoimmune diabetes

  • Text
  • PDF
Abstract

Research Article

Authors

Soon H. Kim, Mary M. Cleary, Howard S. Fox, David Chantry, Nora Sarvetnick

×

Figure 8

Options: View larger image (or click on image) Download as PowerPoint
MDC-mediated acceleration of disease. (a) Acceleration of diabetes in MD...
MDC-mediated acceleration of disease. (a) Acceleration of diabetes in MDC-TG NOD mice. Diabetogenic potential was compared after adoptive transfer of splenocytes from (b) 8-week-old prediabetic (n = 3) or (c) 16- to 18-week-old diabetic (n = 3) MDC-TG and non-TG littermates into 8- to 10-week-old NOD-scid female recipients. Open circles, non-TG NOD littermates; filled circles, MDC-TG NOD mice. (d) MDC-mediated Th1 immune response. Splenocytes from 11-week-old MDC-TG and non-TG NOD females (three mice/group) were stimulated with the islet antigen, GAD65, presented by irradiated spleen cells as APCs. Culture supernatants were analyzed for cytokine secretion by ELISA. T cell proliferation was measured in response to GAD65 presented by APCs (e) or upon stimulation of costimulatory factors such as CD3/CD28 (f). Bars represent mean values ± SEM from two separate experiments. White bars and open circles, non-TG littermates. Black bars and filled circles, MDC-TG NOD females.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts